Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.32 USD | -2.35% |
|
-0.95% | -25.98% |
Jun. 24 | Theravance Biopharma, Inc.(NasdaqGM:TBPH) dropped from S&P Pharmaceuticals Select Industry Index | CI |
May. 23 | Transcript : Theravance Biopharma, Inc. - Special Call |
Evolution of the average Target Price on Theravance Biopharma, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Theravance Biopharma, Inc.
BTIG | |
HC Wainwright | |
SVB Securities LLC | |
JPMorgan Chase | |
SVB Leerink | |
Baird | |
Morgan Stanley | |
Needham & Co. | |
Cowen | |
BofA Securities | |
Evercore ISI |
EPS Revisions
- Stock Market
- Equities
- TBPH Stock
- Consensus Theravance Biopharma, Inc.